OBJECTIVE: To examine the association of concurrent low back pain (LBP), and other musculoskeletal pain comorbidity, with knee pain severity in symptomatic knee osteoarthritis (OA). METHODS: Individuals from the Progression Cohort of the Osteoarthritis Initiative (n=1,389, ages 45-79 years) with symptomatic tibiofemoral knee OA were studied. Participants identified pain in the low back, neck, shoulder, elbow, wrist, hand, hip, knee, ankle, or foot. The primary outcome was the pain subscale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) applied to the more symptomatic knee. We examined WOMAC pain score in persons with and without LBP, before and after adjusting for other musculoskeletal symptoms. RESULTS: Of the participants, 57.4% reported LBP. The mean±SD WOMAC pain score (possible range 0-20) was 6.5±4.1 in participants with and 5.2±3.4 in participants without LBP (P<0.0001). In multivariate analyses, LBP was significantly associated with increased WOMAC knee pain score (β [SE]=1.00 [0.21], P<0.0001). However, pain in all other individual musculoskeletal locations demonstrated similar associations with knee pain score. In models including all pain locations simultaneously, only LBP (β [SE]=0.65 [0.21], P=0.002), ipsilateral elbow pain (β [SE]=0.98 [0.40], P=0.02), and ipsilateral foot pain (β [SE]=1.03 [0.45], P=0.02) were significantly associated with knee pain score. Having >1 pain location was associated with greater WOMAC knee pain; this relationship was strongest for individuals having 4 (β [SE]=1.83 [0.42], P<0.0001) or ≥5 pain locations (β [SE]=1.86 [0.36], P<0.0001). CONCLUSION: LBP, foot pain, and elbow pain are significantly associated with WOMAC knee pain score, as are a higher total number of pain locations. This may have implications for clinical trial planning.
OBJECTIVE: To examine the association of concurrent low back pain (LBP), and other musculoskeletal pain comorbidity, with knee pain severity in symptomatic knee osteoarthritis (OA). METHODS: Individuals from the Progression Cohort of the Osteoarthritis Initiative (n=1,389, ages 45-79 years) with symptomatic tibiofemoral knee OA were studied. Participants identified pain in the low back, neck, shoulder, elbow, wrist, hand, hip, knee, ankle, or foot. The primary outcome was the pain subscale of the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) applied to the more symptomatic knee. We examined WOMAC pain score in persons with and without LBP, before and after adjusting for other musculoskeletal symptoms. RESULTS: Of the participants, 57.4% reported LBP. The mean±SD WOMAC pain score (possible range 0-20) was 6.5±4.1 in participants with and 5.2±3.4 in participants without LBP (P<0.0001). In multivariate analyses, LBP was significantly associated with increased WOMAC knee pain score (β [SE]=1.00 [0.21], P<0.0001). However, pain in all other individual musculoskeletal locations demonstrated similar associations with knee pain score. In models including all pain locations simultaneously, only LBP (β [SE]=0.65 [0.21], P=0.002), ipsilateral elbow pain (β [SE]=0.98 [0.40], P=0.02), and ipsilateral foot pain (β [SE]=1.03 [0.45], P=0.02) were significantly associated with knee pain score. Having >1 pain location was associated with greater WOMAC knee pain; this relationship was strongest for individuals having 4 (β [SE]=1.83 [0.42], P<0.0001) or ≥5 pain locations (β [SE]=1.86 [0.36], P<0.0001). CONCLUSION: LBP, foot pain, and elbow pain are significantly associated with WOMAC knee pain score, as are a higher total number of pain locations. This may have implications for clinical trial planning.
Authors: Adam M Pearson; Jon D Lurie; Emily A Blood; John W Frymoyer; Heike Braeutigam; Howard An; Federico P Girardi; James N Weinstein Journal: Spine (Phila Pa 1976) Date: 2008-12-01 Impact factor: 3.468
Authors: Clermont E Dionne; Kate M Dunn; Peter R Croft; Alf L Nachemson; Rachelle Buchbinder; Bruce F Walker; Mary Wyatt; J David Cassidy; Michel Rossignol; Charlotte Leboeuf-Yde; Jan Hartvigsen; Päivi Leino-Arjas; Ute Latza; Shmuel Reis; Maria Teresa Gil Del Real; Francisco M Kovacs; Birgitta Oberg; Christine Cedraschi; Lex M Bouter; Bart W Koes; H Susan J Picavet; Maurits W van Tulder; Kim Burton; Nadine E Foster; Gary J Macfarlane; Elaine Thomas; Martin Underwood; Gordon Waddell; Paul Shekelle; Ernest Volinn; Michael Von Korff Journal: Spine (Phila Pa 1976) Date: 2008-01-01 Impact factor: 3.468
Authors: Natalia E Morone; Jordan F Karp; Cheryl S Lynch; James E Bost; Samar R El Khoudary; Debra K Weiner Journal: Pain Med Date: 2009-02-25 Impact factor: 3.750
Authors: Kade L Paterson; Rana S Hinman; David J Hunter; Tim V Wrigley; Kim L Bennell Journal: Arthritis Care Res (Hoboken) Date: 2015-07 Impact factor: 4.794
Authors: Smita Rao; K Douglas Gross; Jingbo Niu; Michael C Nevitt; Cora E Lewis; James C Torner; Jean Hietpas; David Felson; Howard J Hillstrom Journal: Arthritis Care Res (Hoboken) Date: 2016-07-27 Impact factor: 4.794
Authors: Thomas J Hoogeboom; Alfons A den Broeder; Rob A de Bie; Cornelia H M van den Ende Journal: Rheumatology (Oxford) Date: 2012-11-30 Impact factor: 7.580
Authors: Kim van Oudenaarde; Nynke M Swart; Johan L Bloem; Sita Ma Bierma-Zeinstra; Paul R Algra; Bart Koes; Jan Verhaar; Rob Ghh Nelissen; Patrick Je Bindels; Pim Aj Luijsterburg; Monique Reijnierse Journal: Br J Gen Pract Date: 2017-12 Impact factor: 5.386
Authors: Nienke Cuperus; Thea P M Vliet Vlieland; Elien A M Mahler; Clarinda C Kersten; Thomas J Hoogeboom; Cornelia H M van den Ende Journal: Rheumatol Int Date: 2014-10-10 Impact factor: 2.631